Furthermore, our studies on the role of SCLC-derived exosomes in the activation of NLRP6 expression indicated that inhibiting the exosome release significantly represses the elevation in NLRP6 expression as well as the MØ M2 switching. The gene discussed is NLRP6; the disease is small cell lung carcinoma.